Theravance Biopharma

TBPH

NASDAQHealth Care

Income Statement

Total Revenue$64.38M

Gross Profit$64.38M

Operating Income$-46.95M

EBITDA$-35.94M

EBIT$-42.07M

Pre-tax Income$136.92M

Net Income$-56.42M

Cash Equivalent$41.17M

Total Debt$47.34M

Book Value$189.94M

Book Value Per Share3.90

Return on Equity (ROE)-32.14%

Return on Assets (ROA)-15.93%

Return on Invested Capital (ROI)-27.40%

Net Profit Margin-87.63%

Current Ratio5.02

Quick Ratio4.89

Long-Term Debt / Equity0.17